Lake Street Maintains Buy on MDxHealth, Lowers Price Target to $3
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Thomas Flaten maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price target from $5 to $3.
Lake Street analyst Thomas Flaten maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price target from $5 to $3.